Overview
Aurora Biolabs is a U.S.-based biotechnology company located in San Diego’s biotech hub, specializing in recombinant protein production, assay development, and drug discovery support services. The company operates as a subsidiary of Structure Based Design (SBD), leveraging decades of scientific expertise in assay development, compound screening, and structural biology. Aurora Biolabs is particularly recognized for its TR-FRET–based assay platforms, which provide highly sensitive and reproducible tools for inhibitor screening and biomarker analysis. Its portfolio includes drug target proteins (e.g., KRAS, PD-L1, kinases), assay kits, and custom services supporting high-throughput screening and therapeutic development. The company emphasizes high purity, biological activity, and consistency, ensuring reliable experimental results for researchers in academia, biotech, and pharmaceutical industries
Key techniques
Aurora Biolabs supports advanced biochemical and drug discovery techniques.
Product lines
Aurora Biolabs offers a combination of high-quality reagents and specialized assay systems for drug discovery
Assay Kits ›
Capabilities
Aurora Biolabs integrates protein science, assay development, and drug discovery expertise
QC & documentation
Aurora Biolabs provides technical validation and documentation to support reliable research outcomes
Lead time & shipping
Delivery timelines depend on product type and customization level